Avsar.
AL

Healthcare · Pharmaceuticals

Albert David Ltd (ALBERTDAVD)

₹830.10

Mkt cap
₹476 Cr
P/E ratio
21.10
P/B
1.21
Div yield
0.60%
ROE
−0.44%
ROCE
0.82%
EPS (TTM)
₹39.34
Book value
₹686
52W range
580–932
Sector
Healthcare

Price history

Previous close

Incorporated in 1938, Albert David Ltd is in the business of manufacturing pharmaceutical products [1]

NSE ALBERTDAVDBSE 524075
Health check
Mixed
ValuationCheap
ProfitabilityWeak
GrowthLow
TechnicalsBullish
52-week range
−10.92% from high
₹830
₹580+43.15% from low₹932
Current
₹830.10
Prev close
₹838.00
Day
−0.94%
Price performance
1D
−0.94%
1W
−1.99%
1M
−4.60%
3M
+17.74%
6M
+26.81%
1Y
+6.92%
YTD
+10.28%

Financials

Revenue, profit & margin
P/E ratio
21.1×
ALBERTDAVD is 39% below the sector median of 34.6×
ALBERTDAVD21.1×
Sector median34.6×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales929388898998837571879086101
Expenses79778079889282808185798391
Operating Profit1316810161-5-11311311
OPM %14%17%9%11%1.0%6%0.8%-6%-15%2.9%12%3.2%10%
Other Income181217102321-9-522-212-2528
Interest0000000011101
Depreciation2122222222232
Profit before tax292723182225-10-128-320-2536
Tax %20%24%20%29%15%28%-8%-13%6%28%23%-15%11%
Net Profit232019131918-9-108-315-2132
EPS in Rs41.1635.5732.8022.6233.0131.66-16.45-18.1013.91-5.7826.81-37.5556.07
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +5.45% · closed higher next day 1 of last 1
 Q1FY27
Broadcast6 Aug '26
Earnings day+5.45%
+1 day+18.77%
+5 days+15.78%
+15 days+28.50%
+30 days+20.32%
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Jun 2026
62.23%Promoter
Promoters62.23%
FIIs0.57%0.01
DIIs1.63%0.02
Public35.56%0.04
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,837.3034.904,40,8300.87%2,901+5.95%15,300+10.46%20.53%
Divi's Lab.₹9,375.0083.542,48,8770.32%902+65.50%3,080+27.80%21.97%
Torrent Pharma.₹4,840.0082.511,84,0980.79%566+5.79%4,921+54.85%15.19%
Zydus Lifesci.₹1,160.0023.771,15,7100.09%990−35.09%8,017+21.96%21.14%
Cipla₹1,394.5031.481,12,6560.93%786−39.19%7,119+2.33%15.49%
Laurus Labs₹1,954.0096.561,05,5770.10%362+125.49%2,026+29.10%17.76%
Aurobindo Pharma₹1,734.0026.3999,7710.23%1,032+28.11%9,150+16.30%12.86%
Albert David₹833.6021.094760.60%32+303.02%101+43.60%0.82%
Median: 158 Co.₹433.9034.562,2050.08%13+29.57%164+18.57%14.96%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2012
Credit ratings6
Rating update 2 JulcareRating update 25 Jun 2025careRating update 4 Jul 2024careRating update 6 Sep 2023careRating update 20 Jun 2023crisilRating update 23 May 2023crisil
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 11 Sep - Newspaper Publication regarding 3rd and 4th reminder for special window for re-lodgement of transfer requests of physical sharesShareholder Meeting / Postal Ballot-Outcome of AGM 29 Aug - Submitted minutes of 87th AGM held on 6 August 2026 via VC/OAVM.Voting Results For The 87Th Annual General Meeting Of The Company. 7 Aug - 87th AGM voting results: all 7 resolutions passed, including Rs.5 dividend and CEO appointment.Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 7 AugAnnouncement under Regulation 30 (LODR)-Newspaper Publication 7 Aug - Newspaper Publication regarding extract of unaudited financial results for the first quarter ended 30th June, 2026